MetaCap

Conexeu Sciences Insider Trades

NASDAQ: CNXUHealth CareIndustrial SpecialtiesUSD

3.89+0.44 (+12.75%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
3 · $838.00K
Sales
0 · $0
Shares bought / sold
1.05M / 0
Net activity
Net buying $838,000

Conexeu Sciences insider activity

Over the last 12 months, Conexeu Sciences insiders reported 11 transactions on SEC Form 4: 3 open-market purchases and 0 sales. Insiders bought $838,000 and sold $0 worth of stock, for net insider buying of $838,000. The most recent filing shows Bogart David Robert (Chief Commercial Officer) reporting a transaction in 750,000 shares at $0.001 on Sep 25, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CNXU's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CNXU insider transactions

Conexeu Sciences insider transactions
DateInsiderTypeSharesValueFiling
Sep 25, 2026Bogart David RobertChief Commercial OfficerOption exercise750,000$750Form 4
Sep 14, 2026Sharpe Jeffrey NathanDirectorOption exercise500,000$500Form 4
Sep 4, 2026Purcell Lynn SebastianDirectorOption exercise217,608$500.50KForm 4
Sep 4, 2026Purcell Lynn SebastianDirectorOption exercise217,608$500.50KForm 4
Jun 18, 2026Wright Michael G.10% OwnerOption exercise250,000$250Form 4
Jun 18, 2026Purcell Lynn SebastianDirectorBuy202,500$162.00KForm 4
May 26, 2026Wright Michael G.10% OwnerOption exercise400,000$400Form 4
May 22, 2026Sharpe Jeffrey NathanDirectorOption exercise500,000$500Form 4
May 14, 2026Lorenc Zbigniew PaulDirectorAward11,175—Form 4
May 12, 2026Purcell Lynn SebastianDirectorBuy422,500$338.00KForm 4
May 12, 2026OnePointTwo Capital Ventures LLC10% OwnerBuy422,500$338.00KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related